ELECTROPHILIC SYNTHESIS OF 6-[F-18]FLUORO-L-DOPA - USE OF 4-O-PIVALOYL-L-DOPA AS A SUITABLE PRECURSOR FOR ROUTINE PRODUCTION

被引:13
作者
ISHIWATA, K [1 ]
ISHII, SI [1 ]
SENDA, M [1 ]
TSUCHIYA, Y [1 ]
TOMIMOTO, K [1 ]
机构
[1] BANYU PHARMACEUT CO LTD,TSUKUBA RES INST,TSUKUBA 30033,JAPAN
关键词
D O I
10.1016/0969-8043(93)90144-Y
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
A method of 6-[F-18]fluoro-L-3,4-dihydroxyphenylalanine (6-[F-18]FDOPA) synthesis suitable for the routine production in human PET studies is described. Direct fluorination of L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine with acetyl [F-18]hypofluorite in acetic acid showed the preferable regioselectivity for 6-[F-18]FDOPA to its 2- and 5-fluoro isomers. The HCI-hydrolysis of the reaction mixture followed by HPLC separation using the buffered physiological saline as an eluting solution, gave a sterile and apyrogenic 6-[18]FDOPA injection for clinical studies: decay-corrected radiochemical yields of 15-21% based on acetyl [F-18]hypofluorite, radiochemical purity of > 97% and preparation time of 60 min.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 10 条
[1]  
ADAM MJ, 1986, APPL RADIAT ISOTOPES, V37, P877
[2]  
ADAM MJ, 1988, APPL RADIAT ISOTOPES, V39, P1203
[3]  
ADAM MJ, 1986, J NUCL MED, V27, P1462
[4]   IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .4. PRODRUGS OF L-DOPA [J].
BODOR, N ;
SLOAN, KB ;
HIGUCHI, T ;
SASAHARA, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (11) :1435-1445
[5]  
COENEN HH, 1988, APPL RADIAT ISOTOPES, V39, P1243
[6]   A NEW POTENTIAL PRODRUG TO IMPROVE THE DURATION OF L-DOPA - L-3-(3-HYDROXY-4-PIVALOYLOXYPHENYL)ALANINE [J].
IHARA, M ;
TSUCHIYA, Y ;
SAWASAKI, Y ;
HISAKA, A ;
TAKEHANA, H ;
TOMIMOTO, K ;
YANO, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (07) :525-529
[7]  
LUXEN A, 1986, J LABELLED COMPD RAD, V23, P1066
[8]  
LUXEN A, 1990, APPL RADIAT ISOTOPES, V41, P275
[9]   FLUORINATION OF SUBSTITUTED VERATROLES VIA REGIOSELECTIVE MERCURATION [J].
LUXEN, A ;
BARRIO, JR .
TETRAHEDRON LETTERS, 1988, 29 (13) :1501-1504
[10]  
LUXEN A, 1992, NUCL MED BIOL, V19, P149, DOI 10.1016/0883-2897(92)90002-G